Search filters

List of works by Tobias Goeser

A Novel Study Design Using Continuous Intravenous and Intraduodenal Infusions of Midazolam and Voriconazole for Mechanistic Quantitative Assessment of Hepatic and Intestinal CYP3A Inhibition

scientific article published on 19 May 2020

A concerted action of HNF4alpha and HNF1alpha links hepatitis B virus replication to hepatocyte differentiation.

scientific article published on 11 March 2008

Acoustic structure quantification ultrasound software proves imprecise in assessing liver fibrosis or cirrhosis in parenchymal liver diseases

scientific article published on 11 October 2014

Activated virus-specific T cells are early indicators of anti-CMV immune reactions in liver transplant patients

scientific article published in May 2002

Cholestatic hepatitis with concomitant nephrotic syndrome due to late syphilis in an immunocompetent 32-year-old man

scientific article published on 05 February 2020

Clinical aspects of the different forms of viral hepatitis and their treatment

scientific article

Comorbid Mental Disorders in Gastroenterology and Hepatology: Prevalence and Psychosocial Needs in Tertiary Care

scientific article published on 13 February 2018

Depolarized Hepatocytes Express the Stem/Progenitor Cell Marker Neighbor of Punc E11 After Bile Duct Ligation in Mice.

scientific article

Differential efficacy of corticosteroids and interferon in a patient with chronic hepatitis C-autoimmune hepatitis overlap syndrome

scientific article published on May 2004

Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial

scientific article published in August 2007

Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients

scientific article published on September 2016

Expression of angiotensin II receptor type 1 is reduced in advanced rat liver fibrosis

scientific article published on 04 April 2007

Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin

scientific article published in April 2006

First evaluation of Neighbor of Punc E11 (NOPE) as a novel marker in human hepatocellular carcinoma

scientific article published on 08 September 2020

Foreign-Body Ingestion: A Rare Cause of Abdominal Pain

scientific article

Hepatocyte expression of angiotensin II type 1 receptor is downregulated in advanced human liver fibrosis

scientific article published on 25 November 2008

Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks

scientific article published on 22 July 2011

Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naïve patients infected with HCV genotype 1

scientific article published on March 2, 2012

Neighbor of Punc E 11: expression pattern of the new hepatic stem/progenitor cell marker during murine liver development

scientific article published on 11 June 2012

Neighbor of Punc E11, a novel oncofetal marker for hepatocellular carcinoma.

scientific article

New cell surface markers for murine fetal hepatic stem cells identified through high density complementary DNA microarrays

scholarly article

Oesophageal and scaly skin lesions associated with chronic cholestatic liver disease

scientific article published on 16 March 2019

Patient- and procedure-related factors affecting proximal and distal detection rates for polyps and adenomas: results from 1603 screening colonoscopies

scientific article published on 15 August 2015

Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3.

scientific article published on June 2004

Percutaneous Endoscopic Gastrostomy in Direct Puncture Technique: When, Why and How?

scientific article published on 20 July 2016

Performance of simple noninvasive scoring systems for the prediction of advanced fibrosis in patients with chronic hepatitis B.

scientific article published on 6 September 2017

Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection

scientific article published in November 2008

Ribavirin priming in patients with chronic hepatitis C and normal ALT: a pilot study.

scientific article

Serrated polyposis syndrome may go undiagnosed even in structured colorectal cancer screening programmes performed by endoscopists with otherwise good quality indices

scientific article published on 21 October 2017

Stepwise Combination of Simple Noninvasive Fibrosis Scoring Systems Increases Diagnostic Accuracy in Nonalcoholic Fatty Liver Disease

scientific article published on September 1, 2013

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

scientific article published on April 2009

Telaprevir is effective given every 8 or 12 hours with ribavirin and peginterferon alfa-2a or -2b to patients with chronic hepatitis C.

scientific article published on 26 October 2010

Telmisartan Plus Propranolol Improves Liver Fibrosis and Bile Duct Proliferation in the PSC-Like Abcb4−/− Mouse Model

scientific article published on December 18, 2012

Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial

scientific article published on June 2003

Viral escape and T-cell immunity during ganciclovir treatment of cytomegalovirus infection: case report of a pancreatico-renal transplant recipient

scientific article published in March 2003

Vital staining of blood vessels and bile ducts with carboxyfluorescein diacetate succinimidyl ester: a novel tool for isolation of cholangiocytes

scientific article published on March 4, 2013

Vitamin D levels vary during antiviral treatment but are unable to predict treatment outcome in HCV genotype 1 infected patients

scientific article